RevBio has received the FDA investigational device exemption (IDE) approval to conduct a clinical trial of its cranial flap bone...
The FDA has granted breakthrough therapy designation to Biogen’s litifilimab for CLE, a chronic autoimmune skin condition.The post FDA grants...
QT Imaging Holdings has announced a new collaboration with Olea Medical to advance cloud-based breast imaging analytics.The post QT Imaging...
Arrowhead Pharmaceuticals has dosed the first participants in its Phase I/IIa clinical trial of ARO-DIMER-PA, an investigational dual functional RNAi...
Arrowhead Pharmaceuticals has dosed the first participants in its Phase I/IIa clinical trial of ARO-DIMER-PA, an investigational dual functional RNAi...
Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical to develop treatments for cardiometabolic diseases.The post Insilico and Qilu...
Myra Vision has enrolled the first patient in the ADAPT clinical trial assessing its Calibreye TGT surgical system in the...
Neurocrine Biosciences has started a Phase II clinical trial of NBI-1065890, a selective VMAT2 inhibitor, in adults with TD.The post...
Eisai and Biogen have announced that the US FDA has accepted for review the sBLA submitted by the former for...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.